In the context of the comprehensive lifting of epidemic prevention measures, the number of newly confirmed cases in the UK has risen sharply again. Health experts warn that a new wave of infection is already on the way.
Data released by the National Bureau of statistics on Friday showed that nearly 990000 people in the UK tested positive for novel coronavirus in the past week, up from about 954000 in the previous week. This is the first increase in the number of confirmed cases of COVID-19 in the UK in the past two months.
This figure is equivalent to 1.5% of the total population in the UK, that is, one in 65 people is infected. At the same time, British health secretary Javed said the country was in a "post epidemic era". In an interview with the times on Saturday, Javed said that the COVID-19 is no longer a pandemic and described it as a endemic disease like influenza. He added: "as a country, we should be proud of the way we solve this problem."
The British National Bureau of Statistics said that the rebound of the epidemic may be due to the infection of Omicron strain ba Subtype 1 and the newer Omicron strain ba 4 subtypes and ba 5 subtype compatible cases increased.
Although cases have increased in all four countries in the UK, the office for National Statistics says the overall trend in Scotland and Wales is "uncertain". These data come from the new crown test results of private families, which can predict the possible development of the epidemic in the next few weeks in advance Some health researchers and doctors warned that the rising trend indicated that a new wave of infection was coming.
Professor Christina pager, director of clinical operation research office of University College London, UK, said last Friday: "the new infection tide has begun. Given our current situation, I expect the number of cases will rise next week."
The data released last Friday was earlier than the platinum Jubilee holiday in Britain. During the holiday, London held a number of celebrations to commemorate the 70th anniversary of Queen Elizabeth's accession to the throne. The British health and safety authority pointed out that this may mean that the data next week will be delayed or distorted to some extent. "Recent data show a slight increase in the number of new crown positives and hospitalizations. These data should be interpreted with caution and may be delayed due to the platinum Jubilee holiday." Simon Clark, an associate professor of cell microbiology at the University of reading, said on Monday that the recent surge in infections was "inevitable" because social activities have resumed and vaccine immunity will decline over time.
Professor Roland Gao, Professor of veterinary epidemiology and data science at the University of Edinburgh in Scotland, pointed out: "the number of people participating in the test is declining, while the number of infection cases is rising. This is not a good prospect, but the most serious impact may not be felt until winter."
Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables or acid ribonucleic . Send an email to: firstname.lastname@example.org and our professional sales engineer will get back to you within 48 hours.
Overview of market area prospect of acid ribonucleic
By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). North America is further divided into countries such as the United States and Canada. The European region is further divided into The United Kingdom, France, Germany, Italy, Spain, Russia and the rest of Europe. The Asia Pacific region is further subdivided into China, Japan, Korea, India, Australia, Southeast Asia and the rest of Asia Pacific. The Latin America region is further subdivided into Brazil, Mexico and the rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa and the rest of MEA.
Market Demand of the acid ribonucleic
The DNA/RNA Extraction Kit market and other acid ribonucleics are projected to grow at a CAGR of 8.26% during the forecast period 2022-2027.
The COVID-19 pandemic has impacted the acid ribonucleic market for a short time due to restrictions on different business and research activities for acid ribonucleics. In addition, diagnostic tests for other diseases and medical conditions in hospitals and other clinical diagnostic facilities have been affected as COVID-19 has led to fewer patients taking tests. However, the high rate of COVID-19 infection and research activities are undertaken by major companies in the field of sequencing to expand their understanding of the virus and its origins, as well as molecular diagnostics of the SARS-COV-2 virus, have led to the development and launch of many DNA - and RNA-BASED COVID-19 kits, The kits proved so important that they were in great demand.
Market drivers for the acid ribonucleic
The growth of the DNA/RNA extraction kit market is primarily driven by increased investment in R&D activities in different areas, including molecular diagnostics for different chronic and infectious diseases. For example, the US spent $842 billion on R&D activities in 2020, followed by China at $664 billion, according to the ORGANISATION for Economic Co-operation and Development. Technological advances worldwide, new product launches by major market players, and an increase in cancer cases are also likely to complement the growth of the markets under study.
Other factors, such as increased demand for automation of DNA/RNA extraction technologies, new user-friendly and easy extraction kits, and DNA/RNA for analysis of new diseases causing microorganisms, are expected to drive DNA/RNA growth. RNA Extraction Kit market during the forecast period. Therefore, low awareness and availability of the kit and low market penetration in less developed and developing regions around the world are the major factors limiting the growth of the DNA/RNA extraction kit market.
North America is expected to dominate the global acid ribonucleic market during the forecast period
North America, which holds a major share in the acid ribonucleic market, is expected to show a similar trend during the forecast period, mainly due to the high level of R&D activity in the region and the presence of major market players in the region constantly developing their products for the markets studied.
In the region, the US is expected to take a major share of the DNA/RNA extraction kit market due to heavy investment in R&D by government and private entities, increased demand for acid ribonucleics, and the rising prevalence of chronic diseases.
The acid ribonucleic professional supplier-Geneture
Geneture is a professional supplier of Nucleic Acid Extraction Reagent,Automatic Nucleic Acid Extraction,Lab consumables, Real-time PCR, Covid-19 Rapid Test Supplier. Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables.
Feel free to get a qutoe send an email to: email@example.com and our professional sales engineer will get back to you within 48 hours.
Tungsten Sulfide (WS2) or Tungsten Disulfide is a very smooth dry film friction coating.…
Lithium stearate is a white powdery compound with the chemical formula LiC18H35O2, also known as lithium octadecanoate and lithium octadecanoate.…
Market Analysis of 555 timer driving a relay Time relay Industry competition and marketizat…